Global Precision Medicine Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS10781 | Category: Healthcare | Pages: 121 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Precision Medicine, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine.

The Precision Medicine market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Precision Medicine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Medicine manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Precision Medicine market size in 2022 is 7330.0 million US dollars, and it is expected to be 16821.8 million US dollars by 2029, with a compound annual growth rate of 12.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Precision Medicine market include Moderna, Inc. (U.S.), Personalis, Inc. (U.S.), CureVac SE (Germany), Celldex Therapeutics (U.S.), and BioNTech SE (Germany). The share of the top 3 players in the Precision Medicine market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Precision Medicine market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Pharmacogenomics accounted for XX% of Precision Medicine market in 2022. Point-of-Care Testing share of XX%.
Diagnostics accounted for XX% of the Precision Medicine market in 2022. Therapeutics accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Precision Medicine market status and forecast by region.
Chapters 2-3: Segmented the global Precision Medicine market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Precision Medicine market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Precision Medicine market country segmentation data.
Chapter 10: Analyzes the main companies in the Precision Medicine industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Moderna, Inc. (U.S.)
Personalis, Inc. (U.S.)
CureVac SE (Germany)
Celldex Therapeutics (U.S.)
BioNTech SE (Germany)
Advaxis, Inc. (U.S.)
Agenus Inc. (U.S.)
Immatics Biotechnologies GmbH (Germany)
Gritstone Oncology (U.S.)
ImmunityBio, Inc. (U.S.)
bioMérieux SA (France)
Bayer AG (Germany)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
F. Hoffmann-La Roche Ltd. (Switzerland)

Types list
Pharmacogenomics
Point-of-Care Testing
Stem Cell Therapy
Pharmacoproteomics
Others

Application list
Diagnostics
Therapeutics
Others

Table of Content

1 Precision Medicine Market Overview
1.1 Precision Medicine Product Overview
1.1.1 Precision Medicine Product Scope
1.1.2 Precision Medicine Market Status and Outlook
1.2 Global Precision Medicine Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Precision Medicine Market Size by Region (2018-2029)
1.4 Global Precision Medicine Historic Market Size by Region (2018-2023)
1.5 Global Precision Medicine Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Precision Medicine Market Size (2018-2029)
1.6.1 North America Precision Medicine Market Size (2018-2029)
1.6.2 Europe Precision Medicine Market Size (2018-2029)
1.6.3 Asia-Pacific Precision Medicine Market Size (2018-2029)
1.6.4 Latin America Precision Medicine Market Size (2018-2029)
1.6.5 Middle East & Africa Precision Medicine Market Size (2018-2029)
2 Precision Medicine Market Overview by Type
2.3 Global Precision Medicine Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Precision Medicine Historic Market Size by Type (2018-2023)
2.5 Global Precision Medicine Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Precision Medicine Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Precision Medicine Market Size Breakdown by Type
2.6.3 Asia-Pacific Precision Medicine Market Size Breakdown by Type
2.6.4 Latin America Precision Medicine Market Size Breakdown by Type
2.6.5 Middle East and Africa Precision Medicine Market Size Breakdown by Type
3 Precision Medicine Market Overview by Application
3.3 Global Precision Medicine Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Precision Medicine Historic Market Size by Application (2018-2023)
3.5 Global Precision Medicine Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Precision Medicine Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Precision Medicine Market Size Breakdown by Application
3.6.3 Asia-Pacific Precision Medicine Market Size Breakdown by Application
3.6.4 Latin America Precision Medicine Market Size Breakdown by Application
3.6.5 Middle East and Africa Precision Medicine Market Size Breakdown by Application
4 Precision Medicine Competition Analysis by Players
4.1 Global Precision Medicine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Precision Medicine as of 2022)
4.3 Date of Key Players Enter into Precision Medicine Market
4.4 Global Top Players Precision Medicine Headquarters and Area Served
4.5 Key Players Precision Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 Precision Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Precision Medicine Market Segment by Country
5.1 North America Precision Medicine Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Precision Medicine Market Segment by Country
6.1 Europe Precision Medicine Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Precision Medicine Market Segment by Country
7.1 Asia-Pacific Precision Medicine Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Precision Medicine Market Segment by Country
8.1 Latin America Precision Medicine Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Precision Medicine Market Segment by Country
9.1 Middle East & Africa Precision Medicine Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Moderna, Inc. (U.S.)
10.1.1 Moderna, Inc. (U.S.) Information
10.1.2 Business Overview
10.1.3 Moderna, Inc. (U.S.) Precision Medicine Revenue, Gross Margin
10.1.4 Precision Medicine Products Offered
10.1.5 Moderna, Inc. (U.S.) Recent Development
10.2  Personalis, Inc. (U.S.)
10.2.1 Personalis, Inc. (U.S.) Information
10.2.2 Business Overview
10.2.3 Personalis, Inc. (U.S.) Precision Medicine Revenue, Gross Margin
10.2.4 Precision Medicine Products Offered
10.2.5 Personalis, Inc. (U.S.) Recent Development
10.3  CureVac SE (Germany)
10.3.1 CureVac SE (Germany) Information
10.3.2 Business Overview
10.3.3 CureVac SE (Germany) Precision Medicine Revenue, Gross Margin
10.3.4 Precision Medicine Products Offered
10.3.5 CureVac SE (Germany) Recent Development
10.4  Celldex Therapeutics (U.S.)
10.4.1 Celldex Therapeutics (U.S.) Information
10.4.2 Business Overview
10.4.3 Celldex Therapeutics (U.S.) Precision Medicine Revenue, Gross Margin
10.4.4 Precision Medicine Products Offered
10.4.5 Celldex Therapeutics (U.S.) Recent Development
10.5  BioNTech SE (Germany)
10.5.1 BioNTech SE (Germany) Information
10.5.2 Business Overview
10.5.3 BioNTech SE (Germany) Precision Medicine Revenue, Gross Margin
10.5.4 Precision Medicine Products Offered
10.5.5 BioNTech SE (Germany) Recent Development
10.6  Advaxis, Inc. (U.S.)
10.6.1 Advaxis, Inc. (U.S.) Information
10.6.2 Business Overview
10.6.3 Advaxis, Inc. (U.S.) Precision Medicine Revenue, Gross Margin
10.6.4 Precision Medicine Products Offered
10.6.5 Advaxis, Inc. (U.S.) Recent Development
10.7  Agenus Inc. (U.S.)
10.7.1 Agenus Inc. (U.S.) Information
10.7.2 Business Overview
10.7.3 Agenus Inc. (U.S.) Precision Medicine Revenue, Gross Margin
10.7.4 Precision Medicine Products Offered
10.7.5 Agenus Inc. (U.S.) Recent Development
10.8  Immatics Biotechnologies GmbH (Germany)
10.8.1 Immatics Biotechnologies GmbH (Germany) Information
10.8.2 Business Overview
10.8.3 Immatics Biotechnologies GmbH (Germany) Precision Medicine Revenue, Gross Margin
10.8.4 Precision Medicine Products Offered
10.8.5 Immatics Biotechnologies GmbH (Germany) Recent Development
10.9  Gritstone Oncology (U.S.)
10.9.1 Gritstone Oncology (U.S.) Information
10.9.2 Business Overview
10.9.3 Gritstone Oncology (U.S.) Precision Medicine Revenue, Gross Margin
10.9.4 Precision Medicine Products Offered
10.9.5 Gritstone Oncology (U.S.) Recent Development
10.10  ImmunityBio, Inc. (U.S.)
10.10.1 ImmunityBio, Inc. (U.S.) Information
10.10.2 Business Overview
10.10.3 ImmunityBio, Inc. (U.S.) Precision Medicine Revenue, Gross Margin
10.10.4 Precision Medicine Products Offered
10.10.5 ImmunityBio, Inc. (U.S.) Recent Development
10.11  bioMérieux SA (France)
10.11.1 bioMérieux SA (France) Information
10.11.2 Business Overview
10.11.3 bioMérieux SA (France) Precision Medicine Revenue, Gross Margin
10.11.4 Precision Medicine Products Offered
10.11.5 bioMérieux SA (France) Recent Development
10.12  Bayer AG (Germany)
10.12.1 Bayer AG (Germany) Information
10.12.2 Business Overview
10.12.3 Bayer AG (Germany) Precision Medicine Revenue, Gross Margin
10.12.4 Precision Medicine Products Offered
10.12.5 Bayer AG (Germany) Recent Development
10.13  Pfizer Inc. (U.S.)
10.13.1 Pfizer Inc. (U.S.) Information
10.13.2 Business Overview
10.13.3 Pfizer Inc. (U.S.) Precision Medicine Revenue, Gross Margin
10.13.4 Precision Medicine Products Offered
10.13.5 Pfizer Inc. (U.S.) Recent Development
10.14  GSK plc (U.K.)
10.14.1 GSK plc (U.K.) Information
10.14.2 Business Overview
10.14.3 GSK plc (U.K.) Precision Medicine Revenue, Gross Margin
10.14.4 Precision Medicine Products Offered
10.14.5 GSK plc (U.K.) Recent Development
10.15  F. Hoffmann-La Roche Ltd. (Switzerland)
10.15.1 F. Hoffmann-La Roche Ltd. (Switzerland) Information
10.15.2 Business Overview
10.15.3 F. Hoffmann-La Roche Ltd. (Switzerland) Precision Medicine Revenue, Gross Margin
10.15.4 Precision Medicine Products Offered
10.15.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
11 Precision Medicine Market Dynamics
11.1 Precision Medicine Industry Trends
11.2 Precision Medicine Growth Drivers
11.3 Precision Medicine Market Challenges
11.4 Precision Medicine Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Precision Medicine Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?